- Home
- BELFB vs NAGE Comparison
BELFB vs NAGE Comparison
Compare BELFB & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BELFB
- NAGE
- Stock Information
- Founded
- BELFB 1949
- NAGE 1999
- Country
- BELFB United States
- NAGE United States
- Employees
- BELFB N/A
- NAGE N/A
- Industry
- BELFB
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- BELFB
- NAGE Health Care
- Exchange
- BELFB Nasdaq
- NAGE Nasdaq
- Market Cap
- BELFB 865.9M
- NAGE 861.0M
- IPO Year
- BELFB N/A
- NAGE N/A
- Fundamental
- Price
- BELFB $98.13
- NAGE $14.31
- Analyst Decision
- BELFB Strong Buy
- NAGE Strong Buy
- Analyst Count
- BELFB 4
- NAGE 3
- Target Price
- BELFB $95.75
- NAGE $16.67
- AVG Volume (30 Days)
- BELFB 162.4K
- NAGE 993.2K
- Earning Date
- BELFB 07-23-2025
- NAGE 08-06-2025
- Dividend Yield
- BELFB 0.29%
- NAGE N/A
- EPS Growth
- BELFB N/A
- NAGE N/A
- EPS
- BELFB 3.42
- NAGE 0.18
- Revenue
- BELFB $558,940,000.00
- NAGE $107,925,000.00
- Revenue This Year
- BELFB $18.21
- NAGE $26.21
- Revenue Next Year
- BELFB $7.91
- NAGE $20.91
- P/E Ratio
- BELFB $28.73
- NAGE $80.24
- Revenue Growth
- BELFB N/A
- NAGE 29.77
- 52 Week Low
- BELFB $58.00
- NAGE $2.41
- 52 Week High
- BELFB $98.43
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- BELFB 75.23
- NAGE N/A
- Support Level
- BELFB $90.52
- NAGE N/A
- Resistance Level
- BELFB $95.00
- NAGE N/A
- Average True Range (ATR)
- BELFB 3.46
- NAGE 0.00
- MACD
- BELFB 0.98
- NAGE 0.00
- Stochastic Oscillator
- BELFB 94.46
- NAGE 0.00
About BELFB Bel Fuse Inc. Class B
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.